# Filing Detail

Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0000950170-24-124664
Filing Date
2024-11-12
Accepted
2024-11-12 08:33:04
Documents
57
Period of Report
2024-09-30

Document Format Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
1 | 10-Q | pali-20240930.htm iXBRL | 10-Q | 1935815
2 | EX-31.1 | pali-ex31_1.htm | EX-31.1 | 16147
3 | EX-31.2 | pali-ex31_2.htm | EX-31.2 | 16378
4 | EX-32.1 | pali-ex32_1.htm | EX-32.1 | 10245
| Complete submission text file | 0000950170-24-124664.txt |  | 6921684

Data Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
5 | XBRL TAXONOMY EXTENSION SCHEMA WITH EMBEDDED LINKBASES DOCUMENT | pali-20240930.xsd | EX-101.SCH | 959802
59 | EXTRACTED XBRL INSTANCE DOCUMENT | pali-20240930_htm.xml | XML | 1037771

Mailing Address 7750 EL CAMINO REAL, SUITE 5200 CARLSBAD CA 92009
Business Address 7750 EL CAMINO REAL, SUITE 5200 CARLSBAD CA 92009 (858) 704-4900
PALISADE BIO, INC. (Filer) CIK: 0001357459 (see all company filings)

EIN.: 522007292 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-33672 | Film No.: 241443754
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)